Substrate‐Based Ligand Design for Phenazine Biosynthesis Enzyme PhzF
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400466 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Janosch Baumgarten und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Medizinische und Pharmazeutische Chemie, Technische Universität Braunschweig, Beethovenstraße 55, Braunschweig, 38106, Germany. Hauptthemen laut MEDLINE: Phenazines, Pseudomonas aeruginosa, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and Culture of Lower Saxony (MWK), "Drug Discovery and Chemical Informatics for Novel Antiinfectives (iCA)", Studienstiftung des Deutschen Volkes.
Abstract (Originalsprache)
The phenazine pyocyanin is an important virulence factor of the pathogen Pseudomonas aeruginosa , which is on the WHO list of antibiotic resistant “priority pathogens”. In this study the isomerase PhzF, a key bacterial enzyme of the pyocyanin biosynthetic pathway, was investigated as a pathoblocker target. The aim of the pathoblocker strategy is to reduce the virulence of the pathogen without killing it, thus preventing the rapid development of resistance. Based on crystal structures of PhzF, derivatives of the inhibitor 3–hydroxyanthranilic acid were designed. Co‐crystal structures of the synthesized derivatives with PhzF revealed spacial limitations of the binding pocket of PhzF in the closed conformation. In contrast, ligands aligned to the open conformation of PhzF provided more room for structural modifications. The intrinsic fluorescence of small 3–hydroxyanthranilic acid derivatives enabled direct affinity determinations using FRET assays. The analysis of structure‐activity relationships showed that the carboxylic acid moiety is essential for binding to the target enzyme. The results of this study provide fundamental structural insights that will be useful for the design of PhzF‐inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut für Medizinische und Pharmazeutische Chemie, Technische Universität Braunschweig, Beethovenstraße 55, Braunschweig, 38106, Germany.
- Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Franz-Liszt-Str. 35a, Braunschweig, 38106, Germany.
- Structure and Function of Proteins (SFPR), Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, Braunschweig, 38124, Germany.
- Institut für Biochemie, Biotechnologie und Bioinformatik, Technische Universität Braunschweig, Rebenring 56, Braunschweig, 38106, Germany.
ORCID-Profile: Janosch Baumgarten, Marie Thiemann, Moritz Zimmermann, Wulf Blankenfeldt, Conrad Kunick
Förderung
- Ministry of Science and Culture of Lower Saxony (MWK)
- "Drug Discovery and Chemical Informatics for Novel Antiinfectives (iCA)"
- Studienstiftung des Deutschen Volkes
- DESY (Hamburg, Germany)
- Helmholtz Association HGF
- PETRA III
Zitieren
APA
Baumgarten, J., Schneider, P., Thiemann, M., Zimmermann, M., Diederich, C., Blankenfeldt, W., & Kunick, C. (2024). Substrate‐Based Ligand Design for Phenazine Biosynthesis Enzyme PhzF. ChemMedChem. https://doi.org/10.1002/cmdc.202400466
Vancouver
Baumgarten J, Schneider P, Thiemann M, Zimmermann M, Diederich C, Blankenfeldt W, et al. Substrate‐Based Ligand Design for Phenazine Biosynthesis Enzyme PhzF. ChemMedChem. 2024. doi:10.1002/cmdc.202400466
BibTeX
@article{Baumgarten2024,
author = {Baumgarten, Janosch and Schneider, Philipp and Thiemann, Marie and Zimmermann, Moritz and Diederich, Christina and Blankenfeldt, Wulf and Kunick, Conrad},
title = {Substrate‐Based Ligand Design for Phenazine Biosynthesis Enzyme PhzF},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400466}
}
EUVIMED